Clinical Trials Logo

Filter by:
NCT ID: NCT05538481 Withdrawn - Neoplasms Clinical Trials

Study to Identify and Measure the Values and Palliative Care Pref. of Hindu Patients and Their Caregivers

Start date: June 2023
Phase:
Study type: Observational

Historically, palliative care in the US has been rooted in the cultural values of a Caucasian, Christian middle class. Greater understanding of how culture influences the delivery of palliative care to minority patients is needed to achieve health equity. The purpose of this study is to learn more about the cultural values (Hindu customs and beliefs) and palliative care (specialized care for people living with a serious illness) preferences of the Hindu community. To the study team's knowledge, there has not been another study that has used a research approach to help better understand and measure the cultural values and palliative care preferences of Hindu participants with cancer and their caregivers.

NCT ID: NCT05538273 Withdrawn - Urinary Retention Clinical Trials

Optimal Management of Urinary Catheter in Gyn Onc

Start date: September 8, 2022
Phase:
Study type: Observational

This is a combined retrospective observational study that will collect data on urinary catheter removal of patients who underwent pelvic surgery by a gynecologic oncologist to assess timing safety and its implications in postoperative care.

NCT ID: NCT05536882 Withdrawn - Clinical trials for Molluscum Contagiosum

MC RCT - BPO vs Adapalene

Start date: May 18, 2022
Phase: Phase 3
Study type: Interventional

Non-blinded randomized controlled trial comparing efficacy of topical benzoyl peroxide 10% (vehicle choice per patient preference: e.g. gel, cream, lotion, wash) to topical adapalene 0.1% gel in the treatment of molluscum contagiosum in children aged 1 year old to 14 years old. - Two treatment wings: topical benzoyl peroxide 10% (vehicle choice per patient preference) applied 1-2x daily as tolerated vs adapalene 0.1% gel applied 1-2x daily as tolerated. - Primary outcome: Complete clearance at 12wks (defined as lack of identifiable papular molluscum contagiosum lesions on physical exam) - Secondary outcomes: % change in lesion count at 12wks.

NCT ID: NCT05535023 Withdrawn - Clinical trials for Head and Neck Cancer

Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma

Start date: August 24, 2022
Phase: Phase 2
Study type: Interventional

To learn if SAR444245 given in combination with cemiplimab can help to kill cancer cells in patients with HPV-related oropharynx cancer who are scheduled to have surgery to remove the disease

NCT ID: NCT05523310 Withdrawn - Migraine Clinical Trials

Observational Study to Assess Migraine Prediction Tool

Start date: May 1, 2023
Phase:
Study type: Observational

This is a prospective, observational study. The participant will be required to approve his/her participation in the study by completing the electronic consent form. Data collected within the first eight weeks (weeks 1-8) will be used to develop the prediction models (either personal or population/group models). The developed algorithm will be freezer and tested against the data collected during weeks 1-8 of a different cohort population

NCT ID: NCT05522946 Withdrawn - Clinical trials for Cognitive Impairment

Circle Game Collaborative--Freddie the Frog

Start date: February 17, 2021
Phase: N/A
Study type: Interventional

Families who have children with disabilities experience more challenges in interacting with their children than families who have children without disabilities. This increased level of burden results in higher rates of emotional stress and hardship for those families. Motivated by the idea of making deeper connections between children with disabilities and their parents, our gaming platform is designed around two key concepts - human touch and collaborative play. Using wearable sensors, conductive fabrics, microcontrollers, and wireless communication, our gaming platform will register and interpret "touch" as a way to interface with game apps and the devices they are installed on. In other words, touch is translated into player input. Thus, rather than interact with an iPad directly, children and their parents interact with each other instead. Our platform engages both parents and children with disabilities equally in order to better focus on their shared physical expression. As touch can be registered from any part of the body, our platform can be used with children with any type of disability and allows for both active and passive participation by children with a severe disability.

NCT ID: NCT05518968 Withdrawn - Depression Clinical Trials

Videoconferencing Acceptance and Commitment Therapy With a Web App Use for Family Caregivers of People With Dementia

Start date: January 1, 2025
Phase: N/A
Study type: Interventional

The purpose of the pilot study is to assess the effects of an 8-week program on improving mental health in depressed family caregivers of people with dementia. The program will involve 8 weekly coach-guided videoconferencing sessions and the use of a web app based on acceptance and commitment therapy (ACT) for 8 weeks. Also, the study aims to understand these caregivers' experiences in the program, including their perspectives on the app features and contents. We aim to recruit 8-10 people for this pilot project. Outcomes regarding caregivers' mental health and ACT processes will be collected at pretest and posttest (after the completion of the 8-week program) and compared over time (i.e., posttest scores compared to pretest). At posttest, acceptability and perceived usability of the app will be evaluated using the 10-item System Usability Scale and 30-40 minute individual interviews.

NCT ID: NCT05518721 Withdrawn - Hallux Rigidus Clinical Trials

Synthetic Cartilage Implant Versus Interposition Arthroplasty in Hallux Rigidus Treatment: A Randomized Clinical Trial

Start date: July 5, 2022
Phase: N/A
Study type: Interventional

A minimum of 100 patients with grade III hallux rigidus will be randomized in two parallel groups for surgical care. The first group will be submitted to the insertion of a synthetic cartilage implant at the metatarsophalangeal (MTP) joint. The second group will receive a dermal interposition arthroplasty at the MTP. Both sides will undergo the same post-operative protocol. Pain, complications, and functional results will be evaluated in a minimal of two years of follow-up.

NCT ID: NCT05509322 Withdrawn - Fertility Risk Clinical Trials

Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial

CARE
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This real-world, interventional sub-study will evaluate the impact of potential payer subsidies for Turtle Health at-home consults on subsequent interactions with the healthcare system within select sub-populations of interest.

NCT ID: NCT05505539 Withdrawn - Oral Leukoplakia Clinical Trials

Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia

OL_5FU
Start date: September 30, 2022
Phase: Phase 1
Study type: Interventional

This is a single center, open-label, interventional pilot study to assess the feasibility, safety, and preliminary efficacy of intralesional 5-FU injections for the treatment of oral leukoplakia (OL).